Aclaris Therapeutics, Inc. Stock Issued During Period, Shares, New Issues
Aclaris Therapeutics, Inc. (ACRS) reported Stock Issued During Period, Shares, New Issues of 3.75 million shares for the 1-month period ending 2017-08-31, per its 10-K filed 2019-03-18.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2019-03-18
- 2017-08-31: Stock Issued During Period, Shares, New Issues 1 month 3.75M shares.
- 2016-11-17: Stock Issued During Period, Shares, New Issues 4.00M shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|---|
| 2017-08-31 | 3.75M shares 10-K · filed 2019-03-18 | |
| 2016-11-17 | 4.00M shares 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |